SCHEMBL20508266

SCHEMBL20508266

Clc1ccc(-c2nnc(-c3cc4ccccc4[nH]3)o2)cc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.56
ALDH1A1 P00352 4/20 0.56
KDM4E B2RXH2 3/20 0.56
CYP1A2 P05177 3/20 0.56
CYP2C19 P33261 2/20 0.56
HSD17B10 Q99714 2/20 0.56
ATM Q13315 1/20 0.56
NPC1 O15118 5/20 0.50
MAPT P10636 2/20 0.50
CYP2C9 P11712 2/20 0.50
HPGD P15428 2/20 0.50
CASP3 P42574 2/20 0.50
SENP8 Q96LD8 2/20 0.50
SENP7 Q9BQF6 2/20 0.50
SENP6 Q9GZR1 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
NOTUM Q6P988 2/20 0.47
MAOB P27338 2/20 0.46
MAOA P21397 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20508275 0.86 RAB9A (0.65) RAB9AALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL23468385 0.85 NOTUM (0.53) RAB9AALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL20508322 0.84 NPC1 (0.61) RAB9AALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL20508319 0.83 NPC1 (0.57) RAB9AALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL20508264 0.83 NPC1 (0.61) RAB9AALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL20508272 0.81 NPC1 (0.54) RAB9AALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL20508265 0.81 HPGD (0.60) RAB9AALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL20508334 0.77 KDM4E (0.51) RAB9AALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL23468384 0.77 S1PR1 (0.51) RAB9AALDH1A1KDM4ECYP1A2CYP2C19
SCHEMBL20508325 0.77 KDM4E (0.68) RAB9AALDH1A1KDM4ECYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11026426-B2 Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents NORTHERN ILLINOIS RESEARCH FOUNDATION (US) 2021-06-08 US disclosed
US-11026426-B2 Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents NORTHERN ILLINOIS RESEARCH FOUNDATION (US) 2021-06-08 US disclosed
US-20180271098-A1 OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180271098-A1 OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS CMPK1, IPMK, ITPA RAB9A 4196/4885ALDH1A1 3151/4885KDM4E 276/4885
US-11026426-B2 Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents CBR3, AOC3, AHR RAB9A 4222/4885ALDH1A1 594/4885KDM4E 2652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.